
    
      To assess the effectiveness and safety of S-1 + Paclitaxel for the peri-operative
      chemotherapy in Chinese patients with unresectable gastric cancer, so as to further find out
      the optimal protocol for the peri-operative chemotherapy in the patients with gastric cancer.
    
  